The Staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) has recently begun issuing comment letters in the life sciences reverse merger (RM) context that involve a broadened...more
1/22/2024
/ Capital Formation ,
Compliance ,
Form 8-K ,
Form S-1 ,
Life Sciences ,
Mergers ,
Publicly-Traded Companies ,
Recapitalization ,
Resales Agreements ,
Reverse Mergers ,
Rule 144 ,
SEC Comment Letter Process ,
Securities and Exchange Commission (SEC) ,
Shell Corporations
The SPAC market has withstood many challenges throughout 2021, including softening of the private investment in public equity (PIPE) market for a majority of the year after a very robust first quarter for initial business...more
1/7/2022
/ Acquisitions ,
Backstop Agreements ,
Breach of Duty ,
Capital Markets ,
Class Action ,
Fiduciary Duty ,
Initial Public Offering (IPO) ,
Investigations ,
Investors ,
Mergers ,
Private Investment in Public Equity (PIPEs) ,
Proposed Legislation ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC) ,
Securities Litigation ,
Securities Regulation ,
Share Redemption ,
Special Purpose Acquisition Companies (SPACs) ,
Target Company
On July 13, 2021, the U.S. Securities and Exchange Commission announced charges against special purpose acquisition corporation Stable Road Acquisition Company, its sponsor SRC-NI, its CEO Brian Kabot, the SPAC’s proposed...more
7/29/2021
/ Acquisitions ,
CEOs ,
Disclosure Requirements ,
Enforcement Actions ,
Mergers ,
Misleading Statements ,
Misrepresentation ,
Omissions ,
Rule 10b-5 ,
Section 17(a) ,
Securities Act of 1933 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Litigation ,
Securities Violations ,
Special Purpose Acquisition Companies (SPACs) ,
Sponsors